An Efficacy Trial in Erlangen, Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP Vaccine (DTaP) or the Lederle Whole-Cell Component DTP Vaccine (DTP). • 714 | Zendy

AI Assistant Blog Pricing

An Efficacy Trial in Erlangen, Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP Vaccine (DTaP) or the Lederle Whole-Cell Component DTP Vaccine (DTP). • 714

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.